TGY2IT
KNSA icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
+34,341
New +$1.78M 0.43% 34

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's KNSA Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 34,341 shares worth $2.2M. The stake represents 0.43% of the portfolio and ranks #34 among its holdings.

94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust held 34,341 shares of Kiniksa Pharmaceuticals worth $2.2M as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Timothy G. Youngquist 2020 Irrevocable Trust position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.43% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #34 holding.
  • 94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.